Elsevier/Gold Standard announces several enhancements to its pricing tool, ProspectoRx, including the addition of Federal Supply Schedule (FSS) pricing, which provides immediate access to competitive federal pricing. ProspectoRx includes extensive information on brand and generic pharmaceuticals, delivering immediate access to price changes and new product information. This tool already includes extensive pricing information, including reported average wholesale price (AWP), wholesale acquisition cost (WAC), direct price (DP), and federal upper limit (CMS-FUL), as well as calculated average wholesale price (C-AWP) 1.20 and 1.25, and calculated federal upper limit (C-CMS-FUL).